Samuel Barone

Samuel B Barone is currently serving as the Chief Medical Officer at Nanoscope Therapeutics Inc., a clinical-stage biopharmaceutical company focusing on severe vision loss in advanced retinal disease. Samuel B is also a Principal at SBMD Innovations, LLC, providing strategic consulting services in various medical fields. With a background in ophthalmology and gene therapy, Samuel B has held positions such as Chief Medical Officer at Gemini Therapeutics, Inc. and Veloce BioPharma LLC. Prior to their industry roles, Samuel B worked as a physician at Retina Associates and served as a Senior Medical Officer at the FDA. Samuel holds an MD from Pennsylvania State University College of Medicine and a BS in Biology from Boston College.